Home ›
Trademark Categories ›
Pharmaceuticals ›
2006 ›
RE ›
REXIBEL
Trademark search for:
REXIBEL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2013-03-13 — Application filed
2013-05-16 — Sn assigned for sect 66a subseq desig from ib
2013-05-18 — Death of international registration
2013-05-20 — Application filed
2013-05-22 — Application filed
2013-05-28 — Application filed
2013-09-12 — Assigned to examiner
2013-09-17 — Final disposition recorded
2013-09-18 — Office action issued
2013-09-18 — Office action issued
2013-09-18 — Office action issued
2013-10-12 — Office action issued
2014-02-25 — Attorney/dom.rep.revoked and/or appointed
2014-02-25 — Teas/email correspondence entered
2014-02-25 — Office action issued
2014-02-25 — Correspondence received in law office
2014-02-25 — Teas revoke/app/change addr of atty/dom rep received
2014-02-27 — Approved for pub - principal register
2014-03-14 — Assigned to lie
2014-03-14 — Law office publication review completed
2014-04-02 — Notice of publication
2014-04-02 — Notification of possible opposition sent to ib
2014-04-02 — Notice of start of opposition period created, to be sent to ib
2014-04-22 — Published for opposition
2014-06-06 — Notification processed by ib
2014-07-08 — Registered-principal register
2014-10-08 — Final disposition recorded
2015-01-08 — Final disposition recorded
2015-01-08 — Final disposition recorded
2015-01-30 — Final disposition recorded
2016-04-28 — International registration renewed
2017-01-31 — Correspondence received in law office
2017-05-23 — Review of correspondence complete - address updated
2021-02-26 — Cancelled section 71
2021-02-26 — Final status recorded
2021-10-26 — Total invalidation of reg ext protection created
2022-02-16 — Total invalidation of reg ext protection sent to ib
2022-02-16 — Invalidation processed
2022-03-12 — Total invalidation processed by the ib
2024-02-26 — New representative at ib received
Owner Information
NOVARTIS AG
CH
NOVARTIS AG
CH
NOVARTIS AG
CH
Correspondent
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C. 4 TIMES SQUARE, 17TH FLOOR New York, NY 10036 UNITED STATES
Filing Details
Filing Date:
2013-03-13
Status Date:
2021-02-26
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.